Filtered By:
Infectious Disease: Tuberculosis

This page shows you your search results in order of relevance. This is page number 13.

Order by Relevance | Date

Total 35529 results found since Jan 2013.

Erratum: Tuberculosis Diagnosis in Children Using Xpert Ultra on Different Respiratory Specimens.
Authors: PMID: 32469281 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - May 30, 2020 Category: Respiratory Medicine Tags: Am J Respir Crit Care Med Source Type: research

Isoniazid Preventive Therapy in Contacts of Multidrug-resistant Tuberculosis.
CONCLUSION: Household contacts who received isoniazid preventive therapy had a lower incidence of tuberculosis disease even when they had been exposed to an index patient with multidrug-resistant tuberculosis. Isoniazid may have a role in the management of latent multidrug-resistant tuberculosis infection. PMID: 32551948 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - June 16, 2020 Category: Respiratory Medicine Authors: Huang CC, Becerra MC, Calderon R, Contreras C, Galea J, Grandjean L, Lecca L, Yataco R, Zhang Z, Murray M Tags: Am J Respir Crit Care Med Source Type: research

Time Dependent Confounding in Tuberculosis Treatment Outcome Analyses: A Review of a Source of Bias.
PMID: 32551891 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - June 17, 2020 Category: Respiratory Medicine Authors: Rodriguez CA, Sy KTL, Mitnick CD, Franke MF Tags: Am J Respir Crit Care Med Source Type: research

A Novel Viral Epidemic Collides with an Ancient Scourge: COVID-19 Associated with Tuberculosis.
PMID: 32609542 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - June 30, 2020 Category: Respiratory Medicine Authors: Cutler T, Scales D, Levine W, Schluger N, O'Donnell M Tags: Am J Respir Crit Care Med Source Type: research

Simplifying Rifapentine Dosing for Tuberculosis Treatment and Prevention.
PMID: 32634022 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - July 6, 2020 Category: Respiratory Medicine Authors: Podany AT Tags: Am J Respir Crit Care Med Source Type: research

Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States.
CONCLUSIONS: In addition to producing major health benefits for high-burden countries, strengthened efforts to achieve effective global TB control could produce substantial health and economic benefits for the United States. PMID: 32645277 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - July 8, 2020 Category: Respiratory Medicine Authors: Menzies NA, Bellerose M, Testa C, Swartwood N, Malyuta Y, Cohen T, Marks SM, Hill AN, Date AA, Maloney SA, Bowden SE, Grills AW, Salomon JA Tags: Am J Respir Crit Care Med Source Type: research

Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid: A Prospective Multi-country Study.
We report frequency of sputum culture conversion within six-months of treatment initiation and risk factors for non-conversion. Methods We included patients with a positive baseline culture who initiated a first endTB regimen prior to April 2018. Two consecutive negative cultures collected > 15 days apart constituted culture conversion. We used generalized mixed models to derive marginal predictions for the probability of culture conversion in key subgroups. Findings 1,109 patients initiated a multidrug treatment containing bedaquiline (63%), delamanid (27%) or both (10%). Of these, 939 (85%) experienced culture convers...
Source: American Journal of Respiratory and Critical Care Medicine - July 23, 2020 Category: Respiratory Medicine Authors: Franke MF, Khan P, Hewison C, Khan U, Huerga H, Seung KJ, Rich ML, Zarli K, Samieva N, Oyewusi L, Nair P, Mudassar M, Melikyan N, Lenggogeni P, Lecca L, Kumsa A, Khan M, Islam S, Hussein K, Docteur W, Chumburidze N, Berikova E, Atshemyan H, Atwood S, Alam Tags: Am J Respir Crit Care Med Source Type: research

Prevention of Multidrug-resistant Tuberculosis in Close Contacts: Back to the Future?
PMID: 32716633 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - July 26, 2020 Category: Respiratory Medicine Authors: Schluger NW Tags: Am J Respir Crit Care Med Source Type: research

Operational Research on the Treatment of Drug-resistant Tuberculosis: Exciting Results that Need to be Protected.
PMID: 32822207 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - August 20, 2020 Category: Respiratory Medicine Authors: O'Donnell M, Mathema B Tags: Am J Respir Crit Care Med Source Type: research

Supporting a Comprehensive, International Approach to Global Tuberculosis Eradication is the Right Thing to Do.
PMID: 32835503 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - August 23, 2020 Category: Respiratory Medicine Authors: Burzynski J, Keshavjee S Tags: Am J Respir Crit Care Med Source Type: research

Erratum: Lower Bacillus Calmette-Gu érin Protection against Mycobacterium tuberculosis Infection after Exposure to Beijing Strains.
Erratum: Lower Bacillus Calmette-Guérin Protection against Mycobacterium tuberculosis Infection after Exposure to Beijing Strains. Am J Respir Crit Care Med. 2020 Sep 15;202(6):909-910 Authors: PMID: 32930635 [PubMed - in process]
Source: American Journal of Respiratory and Critical Care Medicine - September 14, 2020 Category: Respiratory Medicine Tags: Am J Respir Crit Care Med Source Type: research

Prevalence and Population Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study.
Conclusions: While smoking remains the most important risk factor for CAO, in some areas poor education, low BMI and passive smoking are of greater importance. Dusty occupations and tuberculosis are important risk factors at some sites. PMID: 33171069 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - November 10, 2020 Category: Respiratory Medicine Authors: Burney P, Patel J, Minelli C, Gnatiuc L, Amaral AFS, Kocabaş A, Cherkaski HH, Gulsvik A, Nielsen R, Bateman E, Jithoo A, Mortimer K, Sooronbaev TM, Lawin H, Nejjari C, Elbiaze M, El Rhazi K, Zheng JP, Ran P, Welte T, Obaseki D, Erhabor G, Elsony A, Osman Tags: Am J Respir Crit Care Med Source Type: research

Antigen-specific T Cell Activation Distinguishes Between Recent and Remote Tuberculosis Infection.
CONCLUSION: The ΔHLA-DR biomarker can identify individuals with recent QuantiFERON-TB conversion and those with disease progression, allowing targeted provision of preventive treatment to those at highest risk of tuberculosis. Further validation studies of this novel immune biomarker in various settings and populations at risk are warranted. PMID: 33406011 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - January 6, 2021 Category: Respiratory Medicine Authors: Mpande CAM, Musvosvi M, Rozot V, Mosito B, Reid TD, Schreuder C, Lloyd T, Bilek N, Huang H, Obermoser G, Davis MM, Ruhwald M, Hatherill M, Scriba TJ, Nemes E, ACS Study Team Tags: Am J Respir Crit Care Med Source Type: research

New Diagnostics to Infer Risk in Tuberculosis: Is the Term Latent Tuberculosis Infection Obsolete?
PMID: 33596391 [PubMed - as supplied by publisher]
Source: American Journal of Respiratory and Critical Care Medicine - February 17, 2021 Category: Respiratory Medicine Authors: Escalante P, Wilson JW Tags: Am J Respir Crit Care Med Source Type: research

The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control
Publication date: June 2018 Source:Journal of Critical Care, Volume 45 Author(s): Akaninyene Otu, Madiha Hashmi, Ahmed M. Mukhtar, Arthur Kwizera, Simon Tiberi, Bruce Macrae, Alimudin Zumla, Martin W. Dünser, Mervyn Mer Tuberculosis (TB) is one of the top ten causes of death worldwide. In 2016, there were 490,000 cases of multi-drug resistant TB globally. Over 2 billion people have asymptomatic latent Mycobacterium tuberculosis infection. TB represents an important, but neglected management issue in patients presenting to intensive care units. Tuberculosis in intensive care settings may present as the primary diagnosis (...
Source: Journal of Critical Care - March 23, 2018 Category: Gastroenterology Source Type: research